Frontiers of Biostatistical Methods and Applications in Clinical Oncology

¡
¡ Springer
āχ-āĻŦ⧁āĻ•
438
āĻĒ⧃āĻˇā§āĻ āĻž
āϰ⧇āϟāĻŋāĻ‚ āĻ“ āϰāĻŋāĻ­āĻŋāω āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšā§ŸāύāĻŋ  āφāϰāĻ“ āϜāĻžāύ⧁āύ

āĻāχ āχ-āĻŦ⧁āϕ⧇āϰ āĻŦāĻŋāĻˇā§Ÿā§‡

This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and observational studies. The field of cancer clinical studies therefore will continue to provide many new statistical challenges that warrant further progress in the methodology and practice of biostatistics. This book provides a systematic coverage of various stages of cancer clinical studies. Topics from modern cancer clinical trials include phase I clinical trials for combination therapies, exploratory phase II trials with multiple endpoints/treatments, and confirmative biomarker-based phase III trials with interim monitoring and adaptation. It also covers important areas of cancer screening, prognostic analysis, and the analysis of large-scale molecular data in the era of big data.

āϞ⧇āĻ–āĻ• āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇

Shigeyuki Matsui, Professor, Department of Biostatistics, Nagoya University Graduate School of Medicine, [email protected], 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan
John Crowley, President and CEO, Cancer Research and Biostatistics, [email protected], 1730 Minor Ave STE 1900 Seattle, WA 98101-1468

āχ-āĻŦ⧁āϕ⧇ āϰ⧇āϟāĻŋāĻ‚ āĻĻāĻŋāύ

āφāĻĒāύāĻžāϰ āĻŽāϤāĻžāĻŽāϤ āϜāĻžāύāĻžāύāĨ¤

āĻĒāĻ āύ āϤāĻĨā§āϝ

āĻ¸ā§āĻŽāĻžāĻ°ā§āϟāĻĢā§‹āύ āĻāĻŦāĻ‚ āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ
Android āĻāĻŦāĻ‚ iPad/iPhone āĻāϰ āϜāĻ¨ā§āϝ Google Play āĻŦāχ āĻ…ā§āϝāĻžāĻĒ āχāύāĻ¸ā§āϟāϞ āĻ•āϰ⧁āύāĨ¤ āĻāϟāĻŋ āφāĻĒāύāĻžāϰ āĻ…ā§āϝāĻžāĻ•āĻžāωāĻ¨ā§āĻŸā§‡āϰ āϏāĻžāĻĨ⧇ āĻ…āĻŸā§‹āĻŽā§‡āϟāĻŋāĻ• āϏāĻŋāĻ™ā§āĻ• āĻšā§Ÿ āĻ“ āφāĻĒāύāĻŋ āĻ…āύāϞāĻžāχāύ āĻŦāĻž āĻ…āĻĢāϞāĻžāχāύ āϝāĻžāχ āĻĨāĻžāϕ⧁āύ āύāĻž āϕ⧇āύ āφāĻĒāύāĻžāϕ⧇ āĻĒ⧜āϤ⧇ āĻĻā§‡ā§ŸāĨ¤
āĻ˛ā§āϝāĻžāĻĒāϟāĻĒ āĻ“ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžāϰ
Google Play āĻĨ⧇āϕ⧇ āϕ⧇āύāĻž āĻ…āĻĄāĻŋāĻ“āĻŦ⧁āĻ• āφāĻĒāύāĻŋ āĻ•āĻŽā§āĻĒāĻŋāωāϟāĻžāϰ⧇āϰ āĻ“ā§Ÿā§‡āĻŦ āĻŦā§āϰāĻžāωāϜāĻžāϰ⧇ āĻļ⧁āύāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤
eReader āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻĄāĻŋāĻ­āĻžāχāϏ
Kobo eReaders-āĻāϰ āĻŽāϤ⧋ e-ink āĻĄāĻŋāĻ­āĻžāχāϏ⧇ āĻĒāĻĄāĻŧāϤ⧇, āφāĻĒāύāĻžāϕ⧇ āĻāĻ•āϟāĻŋ āĻĢāĻžāχāϞ āĻĄāĻžāωāύāϞ⧋āĻĄ āĻ“ āφāĻĒāύāĻžāϰ āĻĄāĻŋāĻ­āĻžāχāϏ⧇ āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĢāĻžāϰ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻŦā§āϝāĻŦāĻšāĻžāϰāĻ•āĻžāϰ⧀āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āϤ⧈āϰāĻŋ āϏāĻšāĻžā§ŸāϤāĻž āϕ⧇āĻ¨ā§āĻĻā§āϰāϤ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻžāĻŦāϞ⧀ āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰ⧇ āϝ⧇āϏāĻŦ eReader-āĻ āĻĢāĻžāχāϞ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻŦ⧇ āϏ⧇āĻ–āĻžāύ⧇ āĻŸā§āϰāĻžāĻ¨ā§āϏāĻĢāĻžāϰ āĻ•āϰ⧁āύāĨ¤